Tranilast for early-stage diabetic nephropathy
This article has no abstract so we have provided the first paragraph of the full text.
In 2002, Soma et al. showed that tranilast, an antifibrotic drug that suppresses collagen synthesis, slowed the progression of advanced diabetic nephropathy. These researchers have now investigated whether tranilast might also be useful in early-stage diabetic nephropathy.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Replicators lessen transcriptional silencingNature Biotechnology News and Views (01 May 2006)
Chemical biology Dressed-up proteinsNature News and Views (26 Apr 2007)
Mal-function of TLRs by SOCSNature Immunology News and Views (01 Feb 2006)
Solar size variationNature News and Views (31 Jul 1980)
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
